China's CanSino to offer tens of millions of COVID-19 vaccines to COVAX
A logo of China's vaccine specialist CanSino Biologics Inc is pictured on the company's headquarters in Tianjin, China August 17, 2020. [Photo/Agencies]
BEIJING - China's CanSino Biologics Inc has proposed providing "tens of million of doses" of its single-dose COVID-19 vaccine to global vaccine sharing scheme COVAX, Reuters quoted a senior executive of the company as saying.
Pierre Morgon, senior vice president at CanSino, told the media outlet in an interview that the firm made the proposal in December last year to supply vaccines between late 2021 and the end of 2022.
"We are happy to go beyond 2022 if there was still an expectation to do so," Morgon was quoted in the report on Thursday.
The offering to COVAX, which is backed by the World Health Organization, is the lowest price that CanSino uses in markets outside China, where richer countries are subject to prices about three times higher, the report added.
Photos
Related Stories
- El Salvador receives 1st batch of Chinese-made COVID-19 vaccine
- Chinese vaccines rollout gains steam in Zimbabwe
- No geopolitical purpose, political strings behind PLA's COVID-19 vaccine aid: spokesperson
- China's donation of COVID-19 vaccine arrives in Mauritania
- 2nd batch of Sinovac vaccines donated by China arrives in Philippines
- Thai deputy PM gets 2nd Sinovac dose, reaffirms safety of Chinese vaccine
- China's CanSino COVID-19 vaccine approved for emergency use in Hungary
- Benin receives a batch of Sinovac vaccine
- Niger receives COVID-19 vaccines donated by China
- Namibia receives first batch of COVID-19 vaccines from China
Copyright © 2021 People's Daily Online. All Rights Reserved.
